10-K Filing

Oruka Therapeutics, Inc. CIK: 907654 FY 2016

Filing Information

Form Type	10-K
Accession Number	`0001564590-17-004897`
Period End Date	20161231
Filing Date	20170321
Fiscal Year	2016
Fiscal Period	FY
XBRL Instance	abio-20161231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 58 Income Statement 20 Cash Flow Statement 46 Stockholders Equity 19

Balance Sheet 58 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$7.40M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$15.35M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$38.80M	USD	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$13.76M	USD	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$114.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$282.00K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$38.92M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$21.45M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesDebtSecuritiesNoncurrent`	$2.35M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	9.08M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	9.05M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$28.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$66.00K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	9.05M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$630.00K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	9.08M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$766.00K	USD	Point-in-time
Total assets	`Assets`	$39.57M	USD	Point-in-time
Total assets	`Assets`	$24.63M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$364.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.21M	USD	Point-in-time
Accrued compensation and employee benefits	`EmployeeRelatedLiabilitiesCurrent`	$719.00K	USD	Point-in-time
Accrued compensation and employee benefits	`EmployeeRelatedLiabilitiesCurrent`	$669.00K	USD	Point-in-time
Accrued expenses and other liabilities	`OtherAccruedLiabilitiesCurrent`	$472.00K	USD	Point-in-time
Accrued expenses and other liabilities	`OtherAccruedLiabilitiesCurrent`	$471.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.50M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.40M	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$39.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$1.50M	USD	Point-in-time
Total liabilities	`Liabilities`	$2.44M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5 million shares authorized; no shares issued or outstanding at December 31, 2016 and 2015	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5 million shares authorized; no shares issued or outstanding at December 31, 2016 and 2015	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value; 100 million shares authorized at December 31, 2016 and 2015; 9,082,366 and 9,051,217 shares issued and outstanding at December 31, 2016 and 2015, respectively	`CommonStockValue`	$9.00K	USD	Point-in-time
Common stock, $0.001 par value; 100 million shares authorized at December 31, 2016 and 2015; 9,082,366 and 9,051,217 shares issued and outstanding at December 31, 2016 and 2015, respectively	`CommonStockValue`	$9.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$134.72M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$134.13M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-19.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-112.51M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-96.07M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$22.19M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$14.74M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$38.07M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$24.63M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$39.57M	USD	Point-in-time

Income Statement 20 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$7.06M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$12.35M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$4.39M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$4.26M	USD	Annual
Total costs and expenses	`OperatingExpenses`	$16.61M	USD	Annual
Total costs and expenses	`OperatingExpenses`	$11.46M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-16.61M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-11.46M	USD	Annual
Interest and other income	`InterestAndOtherIncome`	$14.00K	USD	Annual
Interest and other income	`InterestAndOtherIncome`	$169.00K	USD	Annual
Interest expense	`InterestExpense`	$4.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-16.44M	USD	Annual
Net loss	`NetIncomeLoss`	$-11.45M	USD	Annual
Change in unrealized loss on marketable securities	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-19.00K	USD	Annual
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-11.45M	USD	Annual
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-16.46M	USD	Annual
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$-1.81	USD	Annual
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$-1.82	USD	Annual
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	9.07M	shares	Annual
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	6.29M	shares	Annual

Cash Flow Statement 46 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-16.44M	USD	Annual
Net loss	`NetIncomeLoss`	$-11.45M	USD	Annual
Depreciation	`DepreciationAndAmortization`	$19.00K	USD	Annual
Depreciation	`DepreciationAndAmortization`	$24.00K	USD	Annual
Amortization of other assets	`AdjustmentForAmortization`	$296.00K	USD	Annual
Amortization of other assets	`AdjustmentForAmortization`	$189.00K	USD	Annual
Amortization of premiums and discounts on marketable securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-161.00K	USD	Annual
Share-based compensation	`ShareBasedCompensation`	$576.00K	USD	Annual
Share-based compensation	`ShareBasedCompensation`	$599.00K	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-213.00K	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$47.00K	USD	Annual
Other assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$432.00K	USD	Annual
Other assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$211.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-431.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$841.00K	USD	Annual
Accrued compensation and employee benefits	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$50.00K	USD	Annual
Accrued compensation and employee benefits	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$340.00K	USD	Annual
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-3.00K	USD	Annual
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$196.00K	USD	Annual
Other	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$-9.00K	USD	Annual
Other	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$-3.00K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-10.53M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-14.99M	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$11.00K	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$12.00K	USD	Annual
Purchases of marketable securities	`PaymentsToAcquireAvailableForSaleSecurities`	$20.50M	USD	Annual
Proceeds from maturities of marketable securities	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$4.10M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-11.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-16.41M	USD	Annual
Proceeds from the issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$37.00M	USD	Annual
Common stock offering costs	`PaymentsOfStockIssuanceCosts`	$2.81M	USD	Annual
Repayment of principal on vendor finance agreement	`RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths`	$193.00K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$33.99M	USD	Annual
Net (decrease) increase in cash and cash equivalents	`NetCashProvidedByUsedInContinuingOperations`	$-31.40M	USD	Annual
Net (decrease) increase in cash and cash equivalents	`NetCashProvidedByUsedInContinuingOperations`	$23.45M	USD	Annual
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$7.40M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$15.35M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$38.80M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$7.40M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$15.35M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$38.80M	USD	Point-in-time
Interest paid	`InterestPaid`	$4.00K	USD	Annual
Common stock offering costs accrued but not yet paid	`CommonStockOfferingCostsAccruedReversalButNotYetPaid`	$11.00K	USD	Annual
Common stock offering costs accrued but not yet paid	`CommonStockOfferingCostsAccruedReversalButNotYetPaid`	$-11.00K	USD	Annual
Change in unrealized loss on marketable securities	`AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLossNetOfTax`	$-19.00K	USD	Annual
Leasehold improvement lease incentive	`NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1`	$48.00K	USD	Annual

Stockholders Equity 19 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance, shares	`CommonStockSharesOutstanding`	9.05M	shares	Point-in-time
Beginning Balance, shares	`CommonStockSharesOutstanding`	9.08M	shares	Point-in-time
Beginning Balance	`StockholdersEquity`	$22.19M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$14.74M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$38.07M	USD	Point-in-time
Issuance of common stock for cash, net of offering costs	`StockIssuedDuringPeriodValueNewIssues`	$34.17M	USD	Annual
Issuance of common stock upon vesting of Restricted Stock Units, value	`StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures`	-	USD	Annual
Issuance of common stock upon vesting of Restricted Stock Units, value	`StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures`	-	USD	Annual
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$599.00K	USD	Annual
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$576.00K	USD	Annual
Change in unrealized loss on marketable securities	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-19.00K	USD	Annual
Other	`AdjustmentsToAdditionalPaidInCapitalOther`	$11.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-16.44M	USD	Annual
Net loss	`NetIncomeLoss`	$-11.45M	USD	Annual
Ending Balance, shares	`CommonStockSharesOutstanding`	9.05M	shares	Point-in-time
Ending Balance, shares	`CommonStockSharesOutstanding`	9.08M	shares	Point-in-time
Ending Balance	`StockholdersEquity`	$22.19M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$14.74M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$38.07M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.